CSIMarket
 
Cti Biopharma Corp   (CTIC)
Other Ticker:  
 
 

Cti Biopharma Cash flow Statement Quarterly

CTIC



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Mar 31 2023)
3 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
9 Months
(Jun 30 2022)
6 Months
(Mar 31 2022)
3 Months
Income -13.42 -92.99 -75.53 -59.83 -37.18
Depreciation & amortization 0.52 1.95 1.42 0.89 0.32
Amortization of Other Assets - - - - -
Increase (Decrease) in Deferred Revenue - - - - -
Restructuring & Impairment Charges - - - - -
Provision for Doubtful Accounts - - - - -
Increase (Decrease) in Inventories -0.04 -0.73 -1.15 -0.70 -0.10
R & D, Environmental and Other Expense - - - - -
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal - - - - -
Share-based Compensation 2.50 10.03 7.04 4.22 1.68
Income (Loss) from Equity Method Investments - - - - -
Foreign Currency Transaction Gain (Loss), Unrealized - - - - -
Induced Conversion Of Convertible Debt Expense - - - - -
Provision For V A T Assessments - - - - -
Gain Loss On Derivative Instruments Net Pretax - - - - -
Research And Development Asset Acquired Other Than Through Business Combination Written Off - - - - -
Increase Decrease In Value Added Tax Liability - - - - -
Revenue Recognition Milestone Method Revenue Recognized - - - - -
Sublease Income Loss - - - - -
Increase Decrease In Contract With Customer Asset - - - - -
Imputed Interest Expense 3.02 2.89 0.61 - 3.77
Income taxes - - - - -
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net - - - - -
Increase (Decrease) in Accounts Receivable -7.57 -15.39 -10.59 -8.16 -2.43
Increase (Decrease) in Accounts Payable and Accrued Liabilities -15.58 7.74 - - -
Increase (Decrease) in Accrued Liabilities - - - - -
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets -0.19 0.46 0.56 0.75 0.45
Other Working Capital - - 7.43 9.72 6.72
Other Noncash Income (Expense) -0.33 -0.27 -0.04 0.00 -0.05
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities - 8.00 5.17 0.00 0.00
Discontinued operations - - - - -
Net Cash flow from Operating Activities -31.10 -81.19 -65.68 -50.22 -29.98
Capital Expenditures - - - -25.00 -
Sale of Capital Items - - - - -
Short-term Investments Proceeds 15.26 - - -29.79 -
Short-term Investments Acq. - - - - -
Real Estate Investments - - - - -
Payments To Acquire Other Assets - - - - -
Restricted Cash and Investments Increase (Decrease) - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Acquisition Net of Cash Acquired - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net - - - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities 15.26 - - -54.79 -
Short-term debt Net - - - - -
Other borrowing transactions - - - -1.28 -1.26
Long-term debt - borrowings 6.50 - - 60.00 60.00
Long-term debt - repayments - - - - -
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock 3.13 - - 48.35 2.70
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net - - - -5.52 -
Payment Of Deemed Dividends On Conversion Of Preferred Stock - - - - -
Conversion Of Stock Amount Converted - 4.11 - 3.37 -
Noncash Issuance Preferred Stock - - - - -
Exchange Of Convertible Notes Payable For Common Stock - - - - -
Proceeds From Issuance Of Preferred Stock Net Of Issuance Costs - - - - -
Proceeds From Milestone Advance - - - - -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 9.63 - - 105.65 61.43
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -31.10 -81.19 -65.68 -75.22 -29.98
Total Cash Flow -6.21 - - 0.65 31.46
Cash & cash equiv. at beg. of the Year - - - - -
Cash & cash equivalents at end of period - - - - -
Cash Interests paid - - - - -
Cash Income taxes paid - - - - -




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com